Breast Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Breast Cancer Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
5.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
5.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
5.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2023)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By Product
5.3.3. By Application
5.3.4. By End-use
5.3.5. By Region

6. North America Breast Cancer Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
6.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
6.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
6.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Breast Cancer Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.1.2.4. By End-use
6.3.2. Canada Breast Cancer Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.2.2.4. By End-use
6.3.3. Mexico Breast Cancer Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By Application
6.3.3.2.4. By End-use

7. Europe Breast Cancer Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
7.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
7.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
7.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Breast Cancer Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.1.2.4. By End-use
7.3.2. United Kingdom Breast Cancer Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.2.2.4. By End-use
7.3.3. France Breast Cancer Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.3.2.4. By End-use
7.3.4. Italy Breast Cancer Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.4.2.4. By End-use
7.3.5. Spain Breast Cancer Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By Application
7.3.5.2.4. By End-use

8. Asia-Pacific Breast Cancer Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
8.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
8.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
8.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Breast Cancer Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.1.2.4. By End-use
8.3.2. Japan Breast Cancer Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.2.2.4. By End-use
8.3.3. India Breast Cancer Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.3.2.4. By End-use
8.3.4. Australia Breast Cancer Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.4.2.4. By End-use
8.3.5. South Korea Breast Cancer Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Application
8.3.5.2.4. By End-use
9. South America Breast Cancer Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
9.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
9.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
9.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Breast Cancer Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.1.2.4. By End-use
9.3.2. Argentina Breast Cancer Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.2.2.4. By End-use
9.3.3. Colombia Breast Cancer Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Application
9.3.3.2.4. By End-use

10. Middle East and Africa Breast Cancer Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
10.2.2. By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy))
10.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
10.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Breast Cancer Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.1.2.4. By End-use
10.3.2. Saudi Arabia Breast Cancer Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.2.2.4. By End-use
10.3.3. UAE Breast Cancer Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By Application
10.3.3.2.4. By End-use
10.3.4. Kuwait Breast Cancer Diagnostics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Product
10.3.4.2.3. By Application
10.3.4.2.4. By End-use

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape
14.1. Hologic Inc
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Genomic Health Inc
14.3. Becton Dickinson & Co Ltd
14.4. Danaher Corp
14.5. Koninklijke Philips NV
14.6. QIAGEN NV
14.7. Thermo Fisher Scientific Inc
14.8. Myriad Genetics Inc
14.9. Argon Medical Devices Inc
14.10. F Hoffmann-La Roche AG

15. Strategic Recommendations

16. About Us & Disclaimer